SAN FRANCISCO -- Older patients' survival in metastatic pancreatic cancer had a significant association with baseline ...
With the FDA approval of Gilead's seladelpar, there have now been two in a matter of weeks. The US agency has cleared seladelpar under the Livdelzi brand name as a second-line therapy for PBC in ...
A Wall St. street sign is seen near the New York Stock Exchange (NYSE) in New York City, U.S., September 17, 2019. REUTERS/Brendan McDermid/File Photo The tepid reception to Venture Global's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback